title: Improvement of accessory symptoms of hypertension by TSUMURA Orengedokuto Extract, a four herbal drugs containing Kampo-Medicine Granules for ethical use: a double-blind, placebo-controlled study.
abstract: A double-blind, placebo-controlled study was conducted to evaluate the efficacy, safety, and utility of TSUMURA Orengedokuto Extract Granules for Ethical Use (TJ-15) as a treatment for the accessory symptoms of hypertension. Two capsules of the study drug were administered orally 3 times daily (i.e., before meals) for 8 weeks. Among 265 patients enrolled in the study, 134 were assigned to the TJ-15 group and 131 were assigned to the placebo group, of whom 204 patients (103 in the TJ-15 group and 101 in the placebo group) were included in the efficacy and utility analyze and 251 patients (128 in the TJ-15 group and 123 in the placebo group) were included in the safety analysis. Efficacy was significantly higher in the TJ-15 group based on the total score for the accessory symptoms of hypertensions which was the primary efficacy endpoint (Wilcoxon's rank sum test, p=0.013). When each accessory symptom of hypertension was assessed separately, efficacy was higher for hot flushes and facial suffusion in the TJ-15 group (Wilcoxon's rank sum test, p=0.034, and 0.022, respectively). There were no significant differences between the TJ-15 and the placebo groups with respect to the decrease of blood pressure or the antihypertensive effect. There was also no significant difference between the two groups with regard to the overall safety rating. The utility rating was significantly higher in the TJ-15 group than in the placebo group (Wilcoxon's rank sum test, p=0.016). In conclusion, TJ-15 was superior to placebo with respect to efficacy, safety, and utility for the treatment of accessory symptoms of hypertension.
authors.affiliation: Second Department of Internal Medicine, Fukuoka University School of Medicine, Fukuoka, Japan. arakawak@jcom.home.ne.jp
authors.forename: K
authors.initials: K
authors.lastname: Arakawa
authors.forename: T
authors.initials: T
authors.lastname: Saruta
authors.forename: K
authors.initials: K
authors.lastname: Abe
authors.forename: O
authors.initials: O
authors.lastname: Iimura
authors.forename: M
authors.initials: M
authors.lastname: Ishii
authors.forename: T
authors.initials: T
authors.lastname: Ogihara
authors.forename: K
authors.initials: K
authors.lastname: Hiwada
authors.forename: K
authors.initials: K
authors.lastname: Fukiyama
authors.forename: M
authors.initials: M
authors.lastname: Fujishima
authors.forename: Y
authors.initials: Y
authors.lastname: Mizuno
authors.forename: T
authors.initials: T
authors.lastname: Kikuchi
authors.forename: S
authors.initials: S
authors.lastname: Takaori
mesh_terms: D000328:Adult; D001007:Anxiety / Q000188:drug therapy / Q000209:etiology; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D004365:Drugs, Chinese Herbal / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D005260:Female; D005483:Flushing / Q000188:drug therapy / Q000209:etiology; D019584:Hot Flashes / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000150:complications*; D007508:Irritable Mood / Q000187:drug effects; D008297:Male; D020835:Medicine, Kampo; D008875:Middle Aged; D015394:Molecular Structure; D008517:Phytotherapy; D010936:Plant Extracts / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000188:drug therapy / Q000209:etiology
chemical_list: D004365:Drugs, Chinese Herbal; D010936:Plant Extracts; C061676:oren gedoku to